Delivery Order SPE2DB24D2010-SPE2DB25FABAU
- Not listed
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $20,861.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal pharmaceutical procurement needs. The work is scheduled for completion by August 1, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $27,254.12, represents a non-competitive set-aside award with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $21,125.75 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. As a child order under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,539.97 to AmerisourceBergen Drug Corp for supply of Descovy 200-25 mg tablets (30-count units). This non-competitive, firm fixed-price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $63,889.39 and is classified as a firm fixed price delivery order with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $84,036.28 and is set to conclude on August 12, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement...
- The Defense Logistics Agency awarded a $10,027.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. The contract, with an ultimate completion date of August 8, 2025, represents a pharmaceutical delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,658.42 to supply Descovy 200-25 mg tablets in quantities of 30, with performance in Conshohocken, Pennsylvania. The award, issued on August 18, 2025, represents a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $34,386.90 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed price, competitively awarded delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger Indefinite...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABAUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and carries an ultimate completion date of September 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime vehicle valued through December 2026 that supports global pharmaceutical supply for military healthcare programs. As a major pharmaceutical distributor and federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, positioning it as a critical vendor within the DLA's medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 9/2/25 |